{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:39:36Z","timestamp":1792802376595,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Prostate cancer is a heterogeneous disease with a slow progression and a highly variable clinical outcome. The tumor suppressor genes <jats:italic>PTEN<\/jats:italic> and <jats:italic>TP53<\/jats:italic> are frequently mutated in prostate cancer and are predictive of early metastatic dissemination and unfavorable patient outcomes. The progression of solid tumors to metastasis is often associated with increased cell plasticity, but the complex events underlying <jats:italic>TP53<\/jats:italic>-loss-induced disease aggressiveness remain incompletely understood. Using genetically engineered mice, we show that <jats:italic>Trp53<\/jats:italic> deficiency in <jats:italic>Pten<\/jats:italic>-null prostatic epithelial cells (PECs) does not impact early cell proliferation and neoplasia formation, nor growth arrest and senescence entry at a later time. However, <jats:italic>Trp53<\/jats:italic>-deficiency enhances invasive adenocarcinoma development and promotes metastatic cell dissemination. Importantly, our single-cell transcriptomic and chromatin accessibility analyses combined with histological examinations uncovered an epithelial cell population characterized by an induction of Jak\/Stat3 signaling and displaying mesenchymal features. Moreover, we show that the transcriptomic signature of this cell population is prominent in tumors of patients with high-risk prostate cancer or metastatic disease. In addition, our in vivo and organoid-based experiments provide evidence that PEC plasticity occurs through bi-directional communication with cancer-associated fibroblasts (CAFs). Thus, our study demonstrates that p53 loss induces a protumorigenic crosstalk between PECs and CAFs, and identifies new vulnerabilities that might be targeted to limit cancer progression.<\/jats:p>","DOI":"10.1038\/s41419-025-07361-1","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T09:40:05Z","timestamp":1737884405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["p53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6223-9015","authenticated-orcid":false,"given":"Darya","family":"Yanushko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5105-4583","authenticated-orcid":false,"given":"Beatriz","family":"German Falcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"El Bizri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4178-8374","authenticated-orcid":false,"given":"Despoina","family":"Pervizou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Dolgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7604-3814","authenticated-orcid":false,"given":"C\u00e9line","family":"Keime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3394-2083","authenticated-orcid":false,"given":"Tao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1562-1451","authenticated-orcid":false,"given":"Christelle","family":"Thibault-Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-6054","authenticated-orcid":false,"given":"Clementine","family":"Le Magnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8980-9193","authenticated-orcid":false,"given":"Sandrine","family":"Henri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-6877","authenticated-orcid":false,"given":"Gilles","family":"Laverny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5555-046X","authenticated-orcid":false,"given":"Daniel","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,26]]},"reference":[{"key":"7361_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA A Cancer J Clin"},{"key":"7361_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.eururo.2018.11.045","volume":"76","author":"AA Hamid","year":"2019","unstructured":"Hamid AA, Gray KP, Shaw G, MacConaill LE, Evan C, Bernard B, et al. Compound genomic alterations of TP53, PTEN, and RB1 tumor suppressors in localized and metastatic prostate cancer. Eur Urol. 2019;76:89\u201397.","journal-title":"Eur Urol"},{"key":"7361_CR3","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"A Abeshouse","year":"2015","unstructured":"Abeshouse A, Ahn J, Akbani R, Ally A, Amin S, Andry CD, et al. The molecular taxonomy of primary prostate cancer. Cell. 2015;163:1011\u201325.","journal-title":"Cell"},{"key":"7361_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrurol.2018.9","volume":"15","author":"T Jamaspishvili","year":"2018","unstructured":"Jamaspishvili T, Berman DM, Ross AE, Scher HI, De Marzo AM, Squire JA, et al. Clinical implications of PTEN loss in prostate cancer. Nat Rev Urol. 2018;15:222\u201334.","journal-title":"Nat Rev Urol"},{"key":"7361_CR5","unstructured":"Teroerde M, Nientiedt C, Duensing A, Hohenfellner M, Stenzinger A, Duensing S. Revisiting the role of p53 in prostate cancer. In: Urology Department, Frimley Park Hospital, Portsmouth Rd, Frimley, Camberley GU16 7UJ, UK, Bott SR, Lim Ng K, editors. Prostate Cancer [Internet]. Exon Publications; 2021. p. 113\u201324. Available from: https:\/\/exonpublications.com\/index.php\/exon\/article\/view\/318"},{"key":"7361_CR6","doi-asserted-by":"publisher","first-page":"110595","DOI":"10.1016\/j.celrep.2022.110595","volume":"39","author":"H Han","year":"2022","unstructured":"Han H, Wang Y, Curto J, Gurrapu S, Laudato S, Rumandla A, et al. Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis. Cell Rep. 2022;39:110595.","journal-title":"Cell Rep"},{"key":"7361_CR7","doi-asserted-by":"publisher","first-page":"eabg5982","DOI":"10.1126\/sciadv.abg5982","volume":"7","author":"MA Abu El Maaty","year":"2021","unstructured":"Abu El Maaty MA, Grelet E, Keime C, Rerra AI, Gantzer J, Emprou C, et al. Single-cell analyses unravel cell type\u2013specific responses to a vitamin D analog in prostatic precancerous lesions. Sci Adv. 2021;7:eabg5982.","journal-title":"Sci Adv"},{"key":"7361_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1101\/gad.315739.118","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev. 2018;32:1105\u201340.","journal-title":"Genes Dev"},{"key":"7361_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41585-021-00561-2","volume":"19","author":"M Baures","year":"2022","unstructured":"Baures M, Dariane C, Tika E, Puig Lombardi E, Barry Delongchamps N, Blanpain C, et al. Prostate luminal progenitor cells: from mouse to human, from health to disease. Nat Rev Urol. 2022;19:201\u201318.","journal-title":"Nat Rev Urol"},{"key":"7361_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/biom13010067","volume":"13","author":"JS Owen","year":"2022","unstructured":"Owen JS, Clayton A, Pearson HB. Cancer-associated fibroblast heterogeneity, activation and function: implications for prostate cancer. Biomolecules. 2022;13:67.","journal-title":"Biomolecules"},{"key":"7361_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41420-020-0272-5","volume":"6","author":"EH Cheteh","year":"2020","unstructured":"Cheteh EH, Sarne V, Ceder S, Bianchi J, Augsten M, Rundqvist H, et al. Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells. Cell Death Discov. 2020;6:42.","journal-title":"Cell Death Discov"},{"key":"7361_CR12","doi-asserted-by":"publisher","first-page":"eabo2295","DOI":"10.1126\/sciadv.abo2295","volume":"8","author":"MA Abu el Maaty","year":"2022","unstructured":"Abu el Maaty MA, Terzic J, Keime C, Rovito D, Lutzing R, Yanushko D, et al. Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression. Sci Adv. 2022;8:eabo2295.","journal-title":"Sci Adv"},{"key":"7361_CR13","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1073\/pnas.0712021105","volume":"105","author":"CK Ratnacaram","year":"2008","unstructured":"Ratnacaram CK, Teletin M, Jiang M, Meng X, Chambon P, Metzger D. Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma. Proc Natl Acad Sci USA. 2008;105:2521\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7361_CR14","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1084\/jem.20171207","volume":"215","author":"M Parisotto","year":"2018","unstructured":"Parisotto M, Grelet E, El Bizri R, Dai Y, Terzic J, Eckert D, et al. PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo. J Exp Med. 2018;215:1749\u201363.","journal-title":"J Exp Med"},{"key":"7361_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nature03918","volume":"436","author":"Z Chen","year":"2005","unstructured":"Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005;436:725\u201330.","journal-title":"Nature"},{"key":"7361_CR16","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:16878.","journal-title":"Sci Rep"},{"key":"7361_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nprot.2016.006","volume":"11","author":"J Drost","year":"2016","unstructured":"Drost J, Karthaus WR, Gao D, Driehuis E, Sawyers CL, Chen Y, et al. Organoid culture systems for prostate epithelial and cancer tissue. Nat Protoc. 2016;11:347\u201358.","journal-title":"Nat Protoc"},{"key":"7361_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/path.5698","volume":"254","author":"R Servant","year":"2021","unstructured":"Servant R, Garioni M, Vlajnic T, Blind M, Pueschel H, M\u00fcller DC, et al. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. J Pathol. 2021;254:543\u201355.","journal-title":"J Pathol"},{"key":"7361_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1293\/tox.2017-0060","volume":"31","author":"E Fujii","year":"2018","unstructured":"Fujii E, Yamazaki M, Kawai S, Ohtani Y, Watanabe T, Kato A, et al. A simple method for histopathological evaluation of organoids. J Toxicol Pathol. 2018;31:81\u20135.","journal-title":"J Toxicol Pathol"},{"key":"7361_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012;487:239\u201343.","journal-title":"Nature"},{"key":"7361_CR21","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci. 1995;92:9363\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"7361_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/pros.24460","volume":"83","author":"MK Graham","year":"2023","unstructured":"Graham MK, Chikarmane R, Wang R, Vaghasia A, Gupta A, Zheng Q, et al. Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate. Prostate. 2023;83:286\u2013303.","journal-title":"Prostate"},{"key":"7361_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Copp\u00e9","year":"2010","unstructured":"Copp\u00e9 JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol Mech Dis. 2010;5:99\u2013118.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"7361_CR24","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7361_CR25","doi-asserted-by":"crossref","unstructured":"Bravo Gonz\u00e1lez-Blas C, De Winter S, Hulselmans G, Hecker N, Matetovici I, Christiaens V, et al. SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks. Nat Methods 2023;9:1355\u20131367. Available from: https:\/\/www.nature.com\/articles\/s41592-023-01938-4.","DOI":"10.1038\/s41592-023-01938-4"},{"key":"7361_CR26","doi-asserted-by":"crossref","unstructured":"Bravo Gonz\u00e1lez-Blas C, De Winter S, Hulselmans G, Hecker N, Matetovici I, Christiaens V, et al. SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks. Nat Methods 2023;9:1355-1367. Available from: https:\/\/www.nature.com\/articles\/s41592-023-01938-4","DOI":"10.1038\/s41592-023-01938-4"},{"key":"7361_CR27","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell\u2013cell communication from combined expression of multi-subunit ligand\u2013receptor complexes. Nat Protoc. 2020;15:1484\u2013506.","journal-title":"Nat Protoc"},{"key":"7361_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"7361_CR29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9:1102\u201323.","journal-title":"Cancer Discov"},{"key":"7361_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214:579\u201396.","journal-title":"J Exp Med"},{"key":"7361_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.5751","volume":"255","author":"DB Joseph","year":"2021","unstructured":"Joseph DB, Henry GH, Malewska A, Reese JC, Mauck RJ, Gahan JC, et al. Single-cell analysis of mouse and human prostate reveals novel fibroblasts with specialized distribution and microenvironment interactions. J Pathol. 2021;255:141\u201354.","journal-title":"J Pathol"},{"key":"7361_CR32","doi-asserted-by":"publisher","first-page":"6036.13","DOI":"10.1038\/s41467-022-33780-1","volume":"13","author":"HY Wong","year":"2022","unstructured":"Wong HY, Sheng Q, Hesterberg AB, Croessmann S, Rios BL, Giri K, et al. Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease. Nat Commun. 2022;13:6036.13.","journal-title":"Nat Commun"},{"key":"7361_CR33","doi-asserted-by":"publisher","first-page":"36442","DOI":"10.1074\/jbc.M504945200","volume":"280","author":"IM Berquin","year":"2005","unstructured":"Berquin IM, Min Y, Wu R, Wu H, Chen YQ. Expression signature of the mouse prostate. J Biol Chem. 2005;280:36442\u201351.","journal-title":"J Biol Chem"},{"key":"7361_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, et al. Identification of the tumour transition states occurring during EMT. Nature. 2018;556:463\u20138.","journal-title":"Nature"},{"key":"7361_CR35","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1158\/0008-5472.CAN-11-3132","volume":"72","author":"DJ Mulholland","year":"2012","unstructured":"Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, et al. Pten loss and RAS\/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem\/progenitor cells. Cancer Res. 2012;72:1878\u201389.","journal-title":"Cancer Res"},{"key":"7361_CR36","doi-asserted-by":"crossref","unstructured":"Aytes A, Mitrofanova A, Kinkade CW, Lefebvre C, Lei M, Phelan V, et al. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proc Natl Acad Sci USA. 2013;110:3506-3515. https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1303558110","DOI":"10.1073\/pnas.1303558110"},{"key":"7361_CR37","doi-asserted-by":"publisher","first-page":"7736","DOI":"10.1038\/ncomms8736","volume":"6","author":"J Pencik","year":"2015","unstructured":"Pencik J, Schlederer M, Gruber W, Unger C, Walker SM, Chalaris A, et al. STAT3 regulated ARF expression suppresses prostate cancer metastasis. Nat Commun. 2015;6:7736.","journal-title":"Nat Commun"},{"key":"7361_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.celrep.2014.08.044","volume":"9","author":"A Toso","year":"2014","unstructured":"Toso A, Revandkar A, Di Mitri D, Guccini I, Proietti M, Sarti M, et al. Enhancing chemotherapy efficacy in Pten -deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep. 2014;9:75\u201389.","journal-title":"Cell Rep"},{"key":"7361_CR39","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1158\/2159-8290.CD-14-1113","volume":"5","author":"DG Nowak","year":"2015","unstructured":"Nowak DG, Cho H, Herzka T, Watrud K, DeMarco DV, Wang VMY, et al. MYC drives Pten\/Trp53 -deficient proliferation and metastasis due to IL6 secretion and AKT suppression via PHLPP2. Cancer Discov. 2015;5:636\u201351.","journal-title":"Cancer Discov"},{"key":"7361_CR40","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","volume":"3","author":"S Deng","year":"2022","unstructured":"Deng S, Wang C, Wang Y, Xu Y, Li X, Johnson NA, et al. Ectopic JAK\u2013STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nat Cancer. 2022;3:1071\u201387.","journal-title":"Nat Cancer"},{"key":"7361_CR41","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1126\/science.abn0478","volume":"377","author":"JM Chan","year":"2022","unstructured":"Chan JM, Zaidi S, Love JR, Zhao JL, Setty M, Wadosky KM, et al. Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling. Science. 2022;377:1180\u201391.","journal-title":"Science"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07361-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07361-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07361-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T09:40:09Z","timestamp":1737884409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07361-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,26]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7361"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07361-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,26]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Animal experiments were approved by the Ethical committee Com\u2019Eth (Comit\u00e9 d\u2019Ethique pour l\u2019Exp\u00e9rimentation Animale, Strasbourg, France), the Ethical committee CE14 (Marseille, France) and the French ministry of Higher Education and Research (APAFIS#36739-2022041912335718 v7, APAFIS #25240-2020042716503331 v5, APAFIS #50927-2024080216587191 v2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"46"}}